Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 8/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 2/20 | 0.51 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.51 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.51 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.51 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.50 |
| ▸ | TSPO | P30536 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30000178 | 0.89 | MAPT (0.60) | CNR2ALDH1A1HPGDTSPO | |
| SCHEMBL23781994 | 0.89 | MAPT (0.60) | CNR2ALDH1A1HPGDTSPO | |
| SCHEMBL9459043 | 0.81 | PTGER4 (0.55) | CNR2ALDH1A1HPGD | |
| SCHEMBL601022 | 0.81 | CNR2 (1.00) | CNR2ALDH1A1HPGDCNR1 | |
| SCHEMBL25515583 | 0.81 | CNR2 (0.56) | CNR2ALDH1A1HPGDCNR1TSPO | |
| SCHEMBL23801739 | 0.77 | KDM4E (0.50) | CNR2ALDH1A1HPGD | |
| SCHEMBL16510400 | 0.77 | GCGR (0.53) | CNR2ALDH1A1HPGDCNR1 | |
| SCHEMBL10579016 | 0.77 | KDM4E (0.67) | CNR2ALDH1A1HPGD | |
| SCHEMBL29528611 | 0.76 | CNR2 (0.74) | CNR2ALDH1A1HPGD | |
| SCHEMBL22722813 | 0.76 | KDM4E (0.65) | CNR2ALDH1A1HPGDSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CNR2 663/4885ALDH1A1 964/4885HPGD 362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.